FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
24 products match “Sanofi Vaccines US Inc.” (finished products)
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| MenQuadfineisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide tetanus toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide tetanus toxoid conjugate antigen | Neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen 10 ug/.5mL + 3 more ingredients | Injection, SolutionIntramuscular | Sanofi Vaccines US Inc. | 49281-590 |
| Beyfortusnirsevimab | Nirsevimab 100 mg/mL | InjectionIntramuscular | Sanofi Vaccines US Inc. | 49281-574 |
| Beyfortusnirsevimab | Nirsevimab 100 mg/mL | InjectionIntramuscular | Sanofi Vaccines US Inc. | 49281-575 |
| Menactraneisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen |
| Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen 4 ug/.5mL + 3 more ingredients |
| Injection, SolutionIntramuscular |
| Sanofi Vaccines US Inc. |
| 49281-589 |
| Flublok Trivalent Northern Hemisphereinfluenza a virus a/missouri/11/2025 (h1n1) recombinant hemagglutinin antigen, influenza a virus a/darwin/1415/2025 (h3n2) recombinant hemagglutinin antigen, and influenza b virus b/pennsylvania/14/2025 recombinant hemagglutinin antigen | Influenza a virus a/missouri/11/2025 (H1n1) recombinant hemagglutinin antigen 45 ug/.5mL + 2 more ingredients | InjectionIntramuscular | Sanofi Vaccines US Inc. | 49281-726 |
|---|
| Fluzone Tiv Sh 2026influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/gp20238/2024 ivr-277 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated) | Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated) 15 ug/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | Sanofi Vaccines US Inc. | 49281-626 |
|---|
| Fluzone Trivalent Northern Hemisphereinfluenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated) | Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated) 15 ug/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | Sanofi Vaccines US Inc. | 49281-645 |
|---|
| Diluentsodium chloride | Sodium chloride 4.5 mg/.5mL | InjectionSubcutaneous | Sanofi Vaccines US Inc. | 49281-912 |
|---|
| Tubersoltuberculin purified protein derivative | Tuberculin purified protein derivative 5 [iU]/.1mL | Injection, SolutionIntradermal | Sanofi Vaccines US Inc. | 49281-752 |
|---|
| Typhim Visalmonella typhi ty2 vi polysaccharide antigen | Salmonella typhi ty2 vi polysaccharide antigen 25 ug/.5mL | Injection, SolutionIntramuscular | Sanofi Vaccines US Inc. | 49281-790 |
|---|
| Ipolpoliovirus type 1 antigen (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus type 3 antigen (formaldehyde inactivated) | Poliovirus type 1 antigen (Formaldehyde inactivated) 40 [D'ag'U]/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | Sanofi Vaccines US Inc. | 49281-860 |
|---|
| Yf-Vaxyellow fever virus strain 17d-204 live antigen | Yellow fever virus strain 17d-204 live antigen 4.74 [PFU]/.5mL | Injection, Powder, Lyophilized, For suspensionSubcutaneous | Sanofi Vaccines US Inc. | 49281-915 |
|---|
| Fluzone HD Tiv Sh 2026influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/gp20238/2024 ivr-277 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated) | Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated) 60 ug/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | Sanofi Vaccines US Inc. | 49281-016 |
|---|
| Imovax Rabiesrabies virus strain pm-1503-3m antigen (propiolactone inactivated) and water | — | Kit | Sanofi Vaccines US Inc. | 49281-252 |
|---|
| Nuvaxovid 2026-27nvx-cov2928 | Nvx-cov2928 5 ug/.5mL | Injection, SuspensionIntramuscular | Sanofi Vaccines US Inc. | 49281-026 |
|---|
| Fluzone High Dose Northern Hemisphereinfluenza a virus a/switzerland/6849/2025 ivr-278 (a/missouri/11/2025 pdm09-like virus) (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated) | Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated) 60 ug/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | Sanofi Vaccines US Inc. | 49281-126 |
|---|
| Tenivacclostridium tetani toxoid antigen (formaldehyde inactivated) and corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | Clostridium tetani toxoid antigen (Formaldehyde inactivated) 5 [Lf]/.5mL; Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 2 [Lf]/.5mL | Injection, SuspensionIntramuscular | Sanofi Vaccines US Inc. | 49281-215 |
|---|
| Daptacelcorynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen | Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 15 [Lf]/.5mL + 5 more ingredients | Injection, SuspensionIntramuscular | Sanofi Vaccines US Inc. | 49281-286 |
|---|
| Fluzone Tiv Sh 2026influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/gp20238/2024 ivr-277 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated) | Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated) 15 ug/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | Sanofi Vaccines US Inc. | 49281-315 |
|---|
| Adacel TDaPclostridium tetani toxoid antigen (formaldehyde inactivated), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen | Clostridium tetani toxoid antigen (Formaldehyde inactivated) 5 [Lf]/.5mL + 5 more ingredients | Injection, SuspensionIntramuscular | Sanofi Vaccines US Inc. | 49281-400 |
|---|